These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 3053940

  • 1. Evaluation of the clinical pharmacological activity of a phlebotonic agent. Application to the study of Daflon 500 mg.
    Duchene Marullaz P, Amiel M, Barbe R.
    Int Angiol; 1988; 7(2 Suppl):25-32. PubMed ID: 3053940
    [Abstract] [Full Text] [Related]

  • 2. Are the phlebotonic properties shown in clinical pharmacology predictive of a therapeutic benefit in chronic venous insufficiency? Our experience with Daflon 500 mg.
    Tsouderos Y.
    Int Angiol; 1989; 8(4 Suppl):53-9. PubMed ID: 2698902
    [Abstract] [Full Text] [Related]

  • 3. Controlled studies of Daflon 500 mg in chronic venous insufficiency.
    Geroulakos G, Nicolaides AN.
    Angiology; 1994 Jun; 45(6 Pt 2):549-53. PubMed ID: 8203786
    [Abstract] [Full Text] [Related]

  • 4. Venous tone: are the phlebotonic properties predictive of a therapeutic benefit? A comprehensive view of our experience with Daflon 500 mg.
    Tsouderos Y.
    Z Kardiol; 1991 Jun; 80 Suppl 7():95-101. PubMed ID: 1792820
    [Abstract] [Full Text] [Related]

  • 5. Advantage of a micronized flavonoidic fraction (Daflon 500 mg) in comparison with a nonmicronized diosmin.
    Amato C.
    Angiology; 1994 Jun; 45(6 Pt 2):531-6. PubMed ID: 8203783
    [Abstract] [Full Text] [Related]

  • 6. Clinical evaluation of a venotropic drug in man. Example of Daflon 500 mg.
    Laurent R, Gilly R, Frileux C.
    Int Angiol; 1988 Jun; 7(2 Suppl):39-43. PubMed ID: 3053942
    [Abstract] [Full Text] [Related]

  • 7. Double blind study of the pharmacodynamic and clinical activities of 5682 SE in venous insufficiency. Advantages of the new micronized form.
    Cospite M, Dominici A.
    Int Angiol; 1989 Jun; 8(4 Suppl):61-5. PubMed ID: 2698903
    [Abstract] [Full Text] [Related]

  • 8. [Study of the pharmacodynamic activity of daflon 500 mg].
    Amiel M, Barbe R.
    Ann Cardiol Angeiol (Paris); 1998 Mar; 47(3):185-8. PubMed ID: 9772947
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative efficacy of a single daily dose of two capsules Cyclo 3 Fort in the morning versus a repeated dose of one capsule morning and noon. A one-month study.
    Boccalon H, Causse C, Yubero L.
    Int Angiol; 1998 Sep; 17(3):155-60. PubMed ID: 9821028
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Therapeutic effectiveness of flavonoids illustrated by daflon 500 mg].
    Hitzenberger G.
    Wien Med Wochenschr; 1997 Sep; 147(18):409-12. PubMed ID: 9454438
    [Abstract] [Full Text] [Related]

  • 14. [The chronobiology and clinical efficacy of Daflon in the treatment of chronic venous insufficiency].
    Menyhelyi G, Acsády G, Hetényi A, Dubeaux D, Radó G.
    Ter Arkh; 1997 Sep; 69(4):46-8. PubMed ID: 9213959
    [No Abstract] [Full Text] [Related]

  • 15. [Controlled study of increasing venous tone in primary varicose veins by oral administration of Ruscus aculeatus and trimethylhespiridinchalcone].
    Weindorf N, Schultz-Ehrenburg U.
    Z Hautkr; 1987 Jan 01; 62(1):28-38. PubMed ID: 3554800
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [A double-blind study comparing the clinical efficacy of the preparation F-117 (hidrosmin) versus diosmin in the treatment of patients with peripheral venous disorders].
    Honorato Pérez J, Arcas Meca R.
    Rev Med Univ Navarra; 1990 Jan 01; 34(2):77-9. PubMed ID: 2130425
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of a 6-month treatment with Daflon 500 mg in patients with venous leg ulcers associated with chronic venous insufficiency.
    Roztocil K, Stvrtinová V, Strejcek J.
    Int Angiol; 2003 Mar 01; 22(1):24-31. PubMed ID: 12771852
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.